Handbook of Cognitive Behavioral Therapy by Disorder Case Studies and Application for Adults, 2023, Pages 1-8

This content aligns with Goal 3: Good Health as well as Goal 17: Partnership for the goals by reviewing cognitive behavioral therapy.
This content aligns with Goal 3: Good Health as well as Goal 17: Partnership for the goals by reviewing equine-assisted services and the benefits to human therapy.
This chapter advances the UN SDG goal 3 and 17 by exploring antiogensin in relation to the treatment of neurological disorders
Elsevier,

COVID-19 in Alzheimer's Disease and Dementia, First Edition, 2023, pp 259-271

This chapter advances the UN SDG goals 3 and 17 discusses the female gender on AD risk.
Elsevier,

COVID-19 in Alzheimer's Disease and Dementia, First Edition, 2023, pp 203-214

This chapter advances the UN SDG goals 3 and 17 discusses the effects COVID had on the lifestyle of patients with AD.
Elsevier,

Medicinal Usage of Cannabis and Cannabinoids, First Edition, 2023, pp 129-134

This chapter advances the UN SDG goals 3 and 17 by reviewing the use of cannabidiol oil for AD patients.
This chapter advances the UN SDG goals 3 and 17 by presenting how studying zebrafish and behavioral models and molecular markers in the study of AD.
Elsevier,

Handbook of Animal Models in Neurological Disorders, First Edition, 2022, pp 31-41

This chapter advances the UN SDG goals 3 and 17 presenting the current mouse models to studying AD.
Elsevier,

Oxidative Stress: Its Mechanisms and Impacts on Human Health and Disease Onset, 2023, Pages 291-297

This chapter advances the UN SDG goal 3 and 17 by discussing how Alzheimer's disease risk factors, as well as the mechanism for onset and progression, are related to elevated oxidative stress.
Elsevier,

Plant Extracts in Neurodegenerative Diseases, First Edition, 2022, pp 1-15

This chapter advances the UN SDG goals 3 and 17 discusses how plant extracts can help decrease AD symptoms.

Pages